Several studies reported that the cadherin/WNT/catenin pathway could be a novel therapeutic target for attenuating airway remodeling in COPD (Nelson and Nusse, 2004; Kneidinger et al., 2011; Eapen and Sohal, 2020). The gene discussed is CDH17; the disease is chronic obstructive pulmonary disease.